Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,089,050
+$128,141 QoQ
Shares Held
20,038
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#1,605
of 4,676 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 2%
None 98%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Palumbo Wealth Management LLC holds $8,213,716 across 6 Drug Manufacturers - General names. JNJ ranks #1 (62.0% of the industry book) .
All Filings in JNJ
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,089,050 | 20,038 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,960,909 | 20,295 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,001,585 | 19,336 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $3,510,927 | 18,935 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,788,145 | 18,253 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,940,177 | 17,729 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,832,335 | 12,670 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,514,360 | 15,515 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,364,868 | 16,180 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,077,034 | 13,130 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,552,196 | 9,903 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,405,176 | 9,022 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $967,464 | 5,845 | Shares | Sole | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||